Fierce Pharma
JUNE 4, 2023
AstraZeneca and Daiichi Sankyo’s Enhertu has already made waves in breast cancer treatment. | AstraZeneca and Daiichi Sankyo’s Enhertu has already made waves in breast cancer treatment. Now, the companies are positioning the HER2 antibody-drug conjugate for expansion into other tumor types with data that researchers view as very compelling.
MedCity News
JUNE 4, 2023
New York-based startup Ezra recently received FDA clearance for an AI tool it plans to use to launch “the world’s first 30-minute full body MRI scan.” The tool, named Ezra Flash, enhances the quality of MR images so that radiologists can detect cancer earlier.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 4, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Viral vectors.
MedCity News
JUNE 4, 2023
A Servier drug candidate acquired as part of a $1.8 billion deal kept a particular type of brain cancer from progressing in a Phase 3 clinical trial. The study results were presented during the 2023 annual meeting of the American Society of Clinical Oncology.
Pharmaceutical Technology
JUNE 4, 2023
Early-stage non-small cell lung cancer (NSCLC) is typically treated with surgery followed by adjuvant therapy (chemo ± radiation) in patients deemed to be at higher risk. The use of a pre-surgical course of drug treatment (neoadjuvant), is not well established thus far and can differ substantially between countries and even hospitals within the same country.
MedCity News
JUNE 4, 2023
Partum Health, a maternal health startup, recently won the consumer/employer track of the MedCity News INVEST Pitch Perfect contest. The direct-to-consumer company supports families during fertility, pregnancy and postpartum.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JUNE 4, 2023
The use of LLMs in healthcare is still incredibly nascent, so many experts are calling for a safety framework to make this uncharted territory feel safer. There are still a lot of unknowns, but avoiding clinical use cases and not inputting patients’ health information seem to be the most important guardrails providers are putting around LLMs at the moment.
Pharmaceutical Technology
JUNE 4, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Transcription factors
PharmaTech
JUNE 4, 2023
Read about how we helped The Clinician increase users to their website by 85%, new users by 92%, and sessions by 94%
Pharmacy Times
JUNE 4, 2023
Biliary tract cancers have become the model for precision oncology because of its complex molecular landscape.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTech
JUNE 4, 2023
A robust marketing strategy is key to building brand equity and an effective, efficient sales pipeline—the overall goal. And the best way to develop that all-important strategy is to take stock of where you’re at and assess your resources. To aid in this self-assessment, we’ve developed The Life Science Marketer’s Checklist of must-haves for marketing professionals in the industry.
Pharmaceutical Commerce
JUNE 4, 2023
undefined
PharmaTech
JUNE 4, 2023
Medical imaging is a key factor in successful clinical trials. At Bracken, our experts bring storied experience from the intersection of medical imaging and clinical research. Our imaging consultants can serve as an intermediary between you and and an imaging CRO to launch a complete and accomplished clinical trial.
Pharmacy Times
JUNE 4, 2023
Expert discusses the long wait for an effective therapeutic option for persistent, recurrent, or metastatic cervical cancer and the potential widespread benefits of antibody drug conjugates like pembrolizumab.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JUNE 4, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on on Innovation in Pharmaceuticals: Transcription facto
Pharmacy Times
JUNE 4, 2023
Expert said these striking results, coupled with benefits across all subgroups and potential overall survival, suggests efficacy for adults with early-stage non-small cell lung cancer.
Pharmacy Times
JUNE 4, 2023
FR alpha expression is limited on normal cells, but upregulated on cancers such as ovarian, endometrial, and triple-negative breast cancers.
Expert insights. Personalized for you.
324 
Let's personalize your content